2021 annual financial data
BriaCell Therapeutics 2021 Operating cash flow
BriaCell Therapeutics 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -9,887,579 USD.
Operating income was -8,715,233 USD and net income was -17,267,003 USD.
Operating cash flow was -9,887,579 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,715,233 USD
- Net income
- -17,267,003 USD
- Operating cash flow
- -9,887,579 USD